To Be Discontinued Injection Anti-Infective
Lincomycin Hydrochloride Inj · 198 days since initial FDA posting
Brand: LINCOCIN
FDA lists Lincomycin Hydrochloride Inj as To Be Discontinued (Pfizer Inc.).
No availability text on this FDA row.
Lincomycin Hydrochloride Injection: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Lincomycin Hydrochloride Injection
- Manufacturer
- Pfizer Inc.
- Dosage Form
- Injection
- Presentation
- Lincocin, Injection, 2 mL multiple dose vial (NDC 0009-0104-04)
- Package NDC
- 0009-0104-04
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Feb 25, 2026
- Last Updated
- Feb 25, 2026
- Therapeutic Category
- Anti-Infective
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.